Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Net Income (2016 - 2025)

Historic Net Income for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Q3 2025 value amounting to -$1.9 million.

  • Cumberland Pharmaceuticals' Net Income fell 2681.1% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 6922.09%. This contributed to the annual value of -$6.4 million for FY2024, which is 178.41% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Net Income of -$1.9 million as of Q3 2025, which was down 2681.1% from -$735207.0 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' Net Income's 5-year high stood at $1.2 million during Q1 2025, with a 5-year trough of -$6.3 million in Q4 2023.
  • For the 4-year period, Cumberland Pharmaceuticals' Net Income averaged around -$814415.2, with its median value being -$735207.0 (2025).
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Net Income plummeted by 120425.22% in 2024 and then skyrocketed by 16560.85% in 2025.
  • Cumberland Pharmaceuticals' Net Income (Quarter) stood at $503318.0 in 2021, then plummeted by 1352.09% to -$6.3 million in 2023, then skyrocketed by 69.82% to -$1.9 million in 2024, then dropped by 2.49% to -$1.9 million in 2025.
  • Its Net Income was -$1.9 million in Q3 2025, compared to -$735207.0 in Q2 2025 and $1.2 million in Q1 2025.